[HTML][HTML] Melanocortin 4 receptor mutation in obesity

GR Sridhar, L Gumpeny - World Journal of Experimental …, 2024 - pmc.ncbi.nlm.nih.gov
Obesity is increasingly prevalent worldwide, with genetic factors contributing to its
development. The hypothalamic leptin-melanocortin pathway is central to the regulation of …

A Menu for Microbes: Unraveling Appetite Regulation and Weight Dynamics Through the Microbiota-Brain Connection Across the Lifespan

G Ribeiro, H Schellekens… - American Journal …, 2025 - journals.physiology.org
Appetite, as the internal drive for food intake, is often dysregulated in a broad spectrum of
conditions associated with over-and under-nutrition across the lifespan. Appetite regulation …

Semaglutide treatment of hypothalamic obesity–a real-life data study

M Svendstrup, AK Rasmussen, C Kistorp, M Klose… - Pituitary, 2024 - Springer
Purpose Patients with tumors involving the hypothalamic region are at high risk of
developing morbid obesity due to disturbances in the appetite regulative nuclei in …

Hypothalamic obesity: from basic mechanisms to clinical perspectives

J Argente, IS Farooqi, JA Chowen… - The Lancet Diabetes & …, 2024 - thelancet.com
Despite the diverse nature of obesity, there is compelling genetic, clinical, and experimental
evidence that endorses the important contribution of brain circuits to this condition. The …

Effects of growth hormone replacement therapy in childhood-onset craniopharyngioma: an updated systematic review and meta-analysis

MMG de Almeida, PHAG de Freitas, ÁMS Simão… - Pituitary, 2025 - Springer
Abstract Purpose Craniopharyngiomas (CPs) often lead to growth hormone deficiency
(GHD) in children. Growth hormone replacement therapy (GHRT) is essential for managing …

Is semaglutide a target therapy for acquired hypothalamic obesity?

F Prodam - Pituitary, 2024 - Springer
Pituitary patients with acquired HO a mean weight loss of 6.3% after 6 months of treatment
with acceptable and manageable side effects (headache, dry mouth, and sleep …

Long-term quality of survival after pediatric low-grade glioma

JM de Bont, AYN Schouten-van Meeteren - Child's Nervous System, 2024 - Springer
Background Low-grade glioma is the most common brain tumor in children with different
modes of treatment and a high overall survival. Low-grade glioma is considered a chronic …

Seipin Deficiency Leads to Energy Dyshomeostasis via Inducing Hypothalamic Neuroinflammation and Aberrant Expression of Neuropeptides

W Cui, H Chen, L Lei, W Wang, KL Lim, C Zhang… - NeuroMolecular …, 2024 - Springer
Seipin is a key regulator of lipid metabolism, the deficiency of which leads to severe
lipodystrophy. Hypothalamus is the pivotal center of brain that modulates appetite and …

The central control of energy metabolism; hypothalamic obesity is not one disease.

HM van Santen - Hormone Research in Paediatrics, 2025 - karger.com
Background The hypothalamus, a neuro-endocrine gland located centrally in the brain,
weighs only on average 4 grams but is the captain on the ship of our energy balance. In the …

Setmelanotide: new promise for the treatment of hypothalamic obesity?

M Tena-Sempere - The lancet. Diabetes & endocrinology, 2024 - pubmed.ncbi.nlm.nih.gov
Setmelanotide: new promise for the treatment of hypothalamic obesity? Setmelanotide: new
promise for the treatment of hypothalamic obesity? Lancet Diabetes Endocrinol. 2024 Jun;12(6):366-367 …